1016274-45-5

Basic information

• Product Name: C₁₀H₁₃NO₃
• Synonyms: C₁₀H₁₃NO₃
• CAS NO: 1016274-45-5
• Molecular Weight: 195.218
• Mol File: 1016274-45-5.mol

Chemical Properties

• CAS DataBase Reference: C₁₀H₁₃NO₃(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₀H₁₃NO₃(1016274-45-5)
• EPA Substance Registry System: C₁₀H₁₃NO₃(1016274-45-5)

Safety Data

• Hazardous Substances Data: 1016274-45-5(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 1378717-51-1 3-(5-amino-2-hydroxy)-phenyl-propionic acid 

Downstream Products

• 1016274-46-6 methyl 3-[2-hydroxy-5-(2-{4-[3-(2-trifluoromethyl-phenyl)-ureido]-phenyl}-acetylamino)-phenyl]-propionate 
• 1355027-75-6 C₂₇H₂₉N₃O₅ 
• 1355027-67-6 [4-{[(4-{[(2,6-dimethylphenyl)carbamoyl]amino}phenyl)acetyl]amino}-2-(3-oxo-3-{[12-({5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}amino)dodecyl]amino}propyl)phenoxy]acetic acid 
• 1355027-66-5 [2-(21-amino-3-oxo-7,10,13,16,19-pentaoxa-4-azahenicos-1-yl)-4-{[(4-{[(2,6-dimethylphenyl)carbamoyl]amino}phenyl)acetyl]amino}phenoxy]acetic acid trifluoroacetate 
• 1355027-79-0 tert-butyl [2-(2,2-dimethyl-4,24-dioxo-3,8,11,14,17,20-hexaoxa-5,23-diazahexacosan-26-yl)-4-{[(4-{[(2,6-dimethylphenyl)carbamoyl]amino}phenyl)acetyl]amino}phenoxy]acetate 
• 1355027-64-3 (2-{3-[(12-aminododecyl)amino]-3-oxopropyl}-4-{[(4-{[(2,6-dimethylphenyl)carbamoyl] amino}phenyl)acetyl]amino}phenoxy)acetic acid trifluoroacetate 
• 1355027-62-1 3-[2-(2-tert-butoxy-2-oxoethoxy)-5-{[(4-{[(2,6-dimethylphenyl)carbamoyl]amino}phenyl)acetyl]amino}phenyl]propanoic acid 
• 1355027-77-8 C₃₉H₄₃N₃O₇ 
• 1355027-76-7 C₃₃H₃₃N₃O₅ 
• 1355027-78-9 tert-butyl (2-[3-({12-[(tert-butoxycarbonyl)amino]dodecyl}amino)-3-oxopropyl]-4-{[(4-{[(2,6-dimethylphenyl)carbamoyl]amino}phenyl)acetyl]amino}phenoxy)acetate 

Relevant articles and documents

A graftable LDV peptidomimetic: Design, synthesis and application to a blood filtration membrane

A graftable LDV (Leu-Asp-Val) peptidomimetic molecule (B-c) has been prepared from 3-(5-amino-2-hydroxy)phenyl-propionic acid, as α4β1 (VLA-4) integrin ligand. For that purpose, the mechanism of 3-(4-azidophenyl)propionic acid rearrangement has been revisited. Activation of Durapore DVPP-hydrophilic membrane, by surface wet chemistry using triazine trifluoride, followed by covalent coupling of B-c produced a modified filter (0.8% of derivatisation from XPS analysis) with improved capacity of leukocyte retention.